Corona vaccination: 44 crore children have to be vaccinated, sick first, healthy later

 | 
vaccination

In the Kovid-19 vaccination of children in the country, priority will be given to such children, who are also suffering from any other diseases. Dr. NK Arora, President of, National Immunization Technical Advisory Group, said that no matter what serious disease these children are suffering from, it is necessary to get them immune to the coronavirus immediately. After these children, the rest of the healthy children will be vaccinated.

vaccination

Dr. Arora said efforts are being made to identify these high-risk children. Children have been kept in this category who are at risk of becoming seriously ill and hospitalized if infected. For this, a priority list will be prepared in the next two weeks.

It is noteworthy that last month the Drug Controller General of India allowed emergency use of DNA-based Zydus Cadila vaccine for children and adults above 12 years of age. Discussions are taking place between the government and the company regarding this and waiting to make it available in the National Immunization Program.

In the combined trial of the vaccine, WHO and AIIMS got 55.7 percent seroprevalence in the group below 18 years and 63.5 percent in the group above 18 years due to this vaccine. This injectable vaccine is being made by Zydus Cadila Company in Ahmedabad.

vaccination

44 crore children to be vaccinated
Dr. Arora said that children can be carriers of this virus, they do not get infected themselves. That's why it's so important to vaccinate the adults who live around them. It gives them a protective circle. The country aims to vaccinate all adults, followed by rapid immunization of around 44 crore children below the age of 18 years.

More vaccines will come by the end of the year
On alternatives to children's vaccines, Dr. Arora said that Kovovax, being made by Serum Institute of India, may be available in the coming weeks. It is for children aged 5 to 17 years. Some other vaccines may also come, which will give up to three options.

Negotiations between the Center and the company are in the final stage
Meanwhile, Karnataka Health Minister K Sudhakar, after meeting Union Health Minister Mansukh Mandaviya on Sunday, said that talks with the Centre's Zydus Cadila company for children's vaccines are in the final stages. The third phase of the nasal vaccine being developed by Bharat Biotech may be tested in November-December.